7.82
price down icon1.14%   -0.09
after-market Handel nachbörslich: 7.82
loading

Fulcrum Therapeutics Inc Aktie (FULC) Neueste Nachrichten

pulisher
Jul 23, 2025

What drives Fulcrum Therapeutics Inc. stock priceFree Investment Portfolio Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Fulcrum Therapeutics Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Fulcrum Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Fulcrum Therapeutics Inc. a good long term investmentHigh-yield growth strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

why fulcrum therapeutics inc. stock attracts strong analyst attentionWeekly Double Return List - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Fulcrum Therapeutics Inc. stock price move sharplyMarket Ready Callouts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Fulcrum Therapeutics Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Fulcrum Therapeutics Inc. stock performs during market volatilitySafe High Return Entry Points - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Fulcrum Therapeutics (FULC) Drops 2.25% Despite 3.25% Intraday Gain - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 11, 2025
pulisher
Jul 11, 2025

Fulcrum Therapeutics Awards Major Stock Options Package Worth $912,600 to Strategic New Hire - Stock Titan

Jul 11, 2025
pulisher
Jul 09, 2025

Fulcrum Therapeutics (FULC) Soars 14.31% on Earnings Report - AInvest

Jul 09, 2025
pulisher
Jun 28, 2025

Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago - Yahoo Finance

Jun 28, 2025
pulisher
Jun 27, 2025

Fulcrum Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 27, 2025
pulisher
Jun 25, 2025

Is Fulcrum Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 21, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) - The Globe and Mail

Jun 21, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Has $432,000 Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Research Analysts Issue Forecasts for FULC FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Citadel Advisors LLC Makes New $69,000 Investment in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Millennium Management LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Comparing Fulcrum Therapeutics (NASDAQ:FULC) and Lakeshore Biopharma (NASDAQ:LSB) - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Two Sigma Investments LP - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FULC Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule - MarketScreener

Jun 06, 2025
pulisher
Jun 06, 2025

Fulcrum Therapeutics Awards Major Stock Options Package: 70,000 Shares at $6.96 Exercise Price - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New Investment in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jun 05, 2025
pulisher
May 30, 2025

Fulcrum Therapeutics (NASDAQ:FULC) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st

May 30, 2025
$23.63
price up icon 3.30%
$36.59
price up icon 1.58%
$103.52
price up icon 0.10%
$27.57
price down icon 1.54%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.65%
Kapitalisierung:     |  Volumen (24h):